Member Info for Elartu

1.80p (148.5k) - 1.81p (525k).

1.92p (100k) - 1.93p (500k). The ability to sell 100k on line is higher than it has been for some time.

Remember that old quote, "You are judged by the company you keep". Well TexRAD are in very good company these days.

Nice find Bo. Check out link below and see what other companies (bottom of page) are Bronze Sponsors alongside TexRAD. You might just recognise one or two names that have connections to the company. http://www.symposium.it/eventi/2017/big-data-radiomics-artificial-intelligence

The 175k and 225k almost certainly Bo. You couldn't sell that many online today but there were plenty being offered until this afternoon.

Now 1.93p - 1.945p. No more buys at 1.93p available.

Current spread not much different than yesterday. Sell 1.93p (25k) - Buy 1.93p (250k) and 1.945p amounts above that.

1.93p (50k) - 1.93p (500k). So good luck trying the decipher buys and sells today.

Reasons not to day trade. 08-Dec-17 13:17:30 1.9484 127,671 Buy £2,488 08-Dec-17 13:14:22 1.9450 256,426 Buy £4,987 ............. Total Bought 384,097 Cost £7,475 11-Dec-17 08:25:24 1.8800 384,097 Sell £7,221 ............. Total Sold... 384,097 Cost £7,221 Overall loss £254 excluding dealing costs.

Here's an interesting snippet. Nvidia have just "introduced TITAN V, the world’s most powerful GPU for the PC". And for what purpose? "With TITAN V, we are putting Volta into the hands of researchers and scientists all over the world. I can’t wait to see their breakthrough discoveries." Now what might this mean for TexRAD? I suspect the future of TexRAD has just expanded exponentially. https://nvidianews.nvidia.com/news/nvidia-titan-v-transforms-the-pc-into-ai-supercomputer

Currently 1.93p (75k) - 1.98p (250k).

Hi Bo, just seen your post. Currently the spread for 200k is 1.87p - 1.905p.

Hopefully this link won't get mangled. Talk with Bruno starts at 07:49. https://audioboom.com/posts/6540792-challenger-acquisitions-chal-tyratech-tyr-and-alan-green-on-advanced-oncotherapy-avo

Hi Bob, sorry but I don't trust the buy / sell ratios at present and have stopped trying to make sense of them. Whoever is manoeuvring the price, and I have to assume it is a large holder such as Trevor Brown, has the field unto himself with so few trades going through currently. I'll just be glad when they have finished trashing the price and things can return to normal. I won't be spending much time watching prices for now. There's little point at present.

The 73rd Korean Congress of Radiology (KCR 2017) took place in Seoul in late October. TexRAD got a couple of mentions in the issued documentation on the Abdomen. Page 17 - SS 10 AB-08 CT texture analysis as a prognostic biomarker in adults with surgically treated mass-forming intrahepatic cholangiocarcinomas (ICCs) Page 23 - SS 15 AB-07 Hepatocellular carcinoma: texture analysis of preoperative CT images as a potential marker of disease free survival https://pdfs.semanticscholar.org/cfc9/338c79c18b7fec0e4b87bb95b6ce87b0148b.pdf

Oops! I forgot the Thursday link. http://archive.rsna.org/2017/Thursday.pdf SSQ10-07 Preoperative Tumor Texture Analysis from MRI Predicts High-Risk Status and Reduced Survival in Endometrial Carcinomas SSQ15-02 CT Texture of Carotid Arteries identifies Vulnerable Plaque in Stroke and Transient Ischaemic Attack: A Preliminary Outcome Study

http://archive.rsna.org/2017/Sunday.pdf SSA07-06 Quantitative CT-Derived Texture Analysis: A Novel Imaging Biomarker for Assessment and Predication of Response to Neoadjuvant Chemotherapy in Patient with Stage I/II Pancreatic Ductal Adenocarcinoma (PanCA) SSA07-09 Quantitative CT-Derived Texture Analysis: A Novel Imaging Biomarker for Predicting Tumor Aggressiveness in Pancreatic Neuroendocrine Neoplasm (PanNET) SSA11-04 Utility of Texture Analysis for Differentiation of Solid Adrenal Lesions SSA11-05 Usefulness of CT Texture Analysis in Characterizing Renal Cancers SSA19-05 Can MR Textural Analysis Improve Detection of Extracapsular Nodal Spread in Patients with Oral Cavity Cancer: A Feasibility Study http://archive.rsna.org/2017/Monday.pdf SSE12-03 Uric Acid versus Non-Uric Acid Urinary Stones: Differentiation with CT Texture Analysis http://archive.rsna.org/2017/Tuesday.pdf SSG11-06 Spectral Dual Energy CT Texture Analysis of Head and Neck Squamous Cell Carcinoma Tumor for Prediction of Cervical Nodal Metastasis SSJ18-06 Parathyroid Adenoma Identification Using Spectral Dual Energy CT Texture Analysis http://archive.rsna.org/2017/Wednesday.pdf RC505-08 Assessment of Tissue Heterogeneity Using MR Textural Analysis for Grading Gliomas SSK07-05 Hepatocellular Carcinoma: Texture Analysis of Preoperative CT Images as a Potential Marker of Disease-Free Survival SSM05-02 Can CT Textural Analysis Predict the World Health Organization (WHO) Classification of Thymic Epithelial Neoplasms? SSM08-01 Impact of Iterative Reconstruction Algorithms on CT Texture Features of the Liver Parenchyma SSM13-06 Texture Analysis of 68Ga-DOTATATE Positron Emission Tomography and Computed Tomography Images as a Prognostic Biomarker in Adults with Neuro-Endocrine Cancers Treated with 177LuDOTATATE SSQ10-07 Preoperative Tumor Texture Analysis from MRI Predicts High-Risk Status and Reduced Survival in Endometrial Carcinomas SSQ15-02 CT Texture of Carotid Arteries identifies Vulnerable Plaque in Stroke and Transient Ischaemic Attack: A Preliminary Outcome Study http://archive.rsna.org/2017/Friday.pdf

Bob, the NHS had earmarked TexRAD as an "emerging medical device" with "diagnostics that have the potential to positively impact upon the NHS within the next two years" back in October 2015. I think you can safely assume that it will be "an off the chart money spinner". See below link for the original RNS. http://www.fbk.com/nhs-publication-on-potential-application-of-texrad/

https://www.investegate.co.uk/feedback-plc--fdbk-/rns/result-of-agm/201711301638540465Y/

Hi Bob, no idea about trades today as I wasn't around this morning. Lately, the prices have been messed about with so much that I've given up hope of decoding what has really been happening. I can't see a major price movement whilst the seller remains. Any buyer is just picking up shares sold. They don't want to be aggressive in their buying at present. Have decided not to attend the AGM. Sent my voting intentions back 10 days or so ago. If this year's AGM is only going to last 7 minutes I've probably done the right thing. Lot of travelling for 7 minutes and, besides, I've got the remains of a nasty cold to shake off right now. Maybe it will last longer than 7 minutes if TB turns up though.